肝门部胆管癌是指位于左右肝管至胆囊管开口以上部位的胆道肿瘤,占胆管癌50%~70%。外科根治性切除仍然为首选治疗方式。但肝门部胆管癌早期常无特殊临床表现,不易早期诊断,许多病例发现时已达中晚期,手术切除率低,术后复发率高,预后差。近年来,随着介入技术的迅速发展,经皮肝穿 Hilar cholangiocarcinoma is located in the left and right hepatic duct up to the opening of the cystic duct bile duct tumors, accounting for 50% to 70% of cholangiocarcinoma. Radical surgical resection is still the preferred treatment. However, early hilar cholangiocarcinoma often no special clinical manifestations, early diagnosis is not easy, many cases have been found in the late stage, low surgical resection rate, postoperative recurrence rate, poor prognosis. In recent years, with the rapid development of interventional technology, percutaneous liver wear